{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:49:31Z","timestamp":1791668971476,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcard.2026.134758","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:37:55Z","timestamp":1788244675000},"page":"134758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From evidence to delivery: Optimising SGLT2 inhibitor therapy in heart failure"],"prefix":"10.1016","volume":"464","author":[{"given":"Takahiro","family":"Jimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134758_bb0005","first-page":"1","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcard.2026.134758_bb0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2026.134758_bb0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon Scott","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134758_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2026.134683","article-title":"Temporal trends and factors associated with SGLT2 inhibitor prescription in a nationwide French heart failure remote monitoring program","author":"Monzo","year":"2026","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2026.134758_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jamacardio.2025.2145","article-title":"Sodium-glucose cotransporter 2 inhibitor use for heart failure in US ambulatory cardiovascular care","volume":"10","author":"El Rafei","year":"2025","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.134758_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcag063","article-title":"Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry","author":"Ferrannini","year":"2026","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"7","key":"10.1016\/j.ijcard.2026.134758_bb0035","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1161\/CIR.0000000000001455","article-title":"AHA\/ACC\/ESC\/WHF expert consensus document: second universal definition of heart failure (2026)","volume":"154","author":"Walsh","year":"2026","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ijcard.2026.134758_bb0040","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jacc.2023.03.390","article-title":"Efficacy of Empagliflozin in patients with heart failure across kidney risk categories","volume":"81","author":"Butler","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134758_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvae094","article-title":"Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study","author":"Jimba","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"15","key":"10.1016\/j.ijcard.2026.134758_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.048748","article-title":"Association of SGLT2 inhibitor use with outcomes in patients with frailty hospitalized for acute heart failure: insights from a multicenter Japanese registry","volume":"15","author":"Naito","year":"2026","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600608X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600608X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:18:05Z","timestamp":1791667085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732600608X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"alternative-id":["S016752732600608X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134758","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From evidence to delivery: Optimising SGLT2 inhibitor therapy in heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134758"}}